(Q48747897)

15 February 2018

title

Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis. (English)

1 reference

15 February 2018

0 references

1 reference

J Iwamoto

1

1 reference

15 February 2018

K Makita

2

1 reference

15 February 2018

Y Sato

3

1 reference

15 February 2018

T Takeda

4

1 reference

15 February 2018

H Matsumoto

5

1 reference

15 February 2018

language of work or name

English

0 references

publication date

23 November 2010

1 reference

15 February 2018

Osteoporosis International

published in

1 reference

15 February 2018

volume

22

1 reference

15 February 2018

issue

10

1 reference

15 February 2018

page(s)

2735-2742

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00198-010-1495-8

exact match

0 references

cites work

Molecular mechanisms of action of bisphosphonates.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Synthesis of eel-calcitonin and (asu1,7)-eel-calcitonin: contribution of the disulfide bond to the hormonal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Alendronate improves QOL of postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Diagnostic criteria for primary osteoporosis: year 2000 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

The Face Scale: a brief, nonverbal method for assessing patient mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Ovariectomy-induced hyperalgesia and antinociceptive effect of elcatonin, a synthetic eel calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Analgesic effect of two calcitonins and in vitro interaction with opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Comparison of effects of alendronate and raloxifene on lumbar bone mineral density, bone turnover, and lipid metabolism in elderly women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Alendronate in the treatment of avascular necrosis of the hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Quality of life and pain in premenopausal women with major depressive disorder: the POWER Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Sensory innervation of lumbar vertebral bodies in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Fracture prediction from bone mineral density in Japanese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures

21 January 2018

1 reference

12 December 2020

Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments

1 reference

12 December 2020

Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.

1 reference

12 December 2020

Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures

1 reference

12 December 2020

Characteristics of sensory dorsal root ganglia neurons innervating the lumbar vertebral body in rats

1 reference

12 December 2020

Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)

1 reference

12 December 2020

Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain

1 reference

12 December 2020

Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures

1 reference

12 December 2020

Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Endoneurial injection of TNF-alpha produces neuropathic pain behaviors.

1 reference

12 December 2020

Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Sensory and sympathetic innervation of the vertebral endplate in patients with degenerative disc disease

1 reference

12 December 2020

10.1007/S00198-010-1495-8

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018